India and US Agree to Coordinated Action Against Emerging Drug Threats at High-Level Meeting

India and the United States have agreed to undertake coordinated action to address emerging narcotic threats following a recently concluded high-level meeting. The Narcotics Control Bureau (NCB) hosted the 2nd India-United States of America Drug Policy Executive Working Group Meeting on November 2-3, according to a statement released by the federal anti-narcotics agency on Tuesday.

The Indian delegation during the meeting was led by NCB Director General Anurag. The United States side was headed by Debbie Seguin, Acting Deputy Director of the Office of National Drug Control Policy (ONDCP).

Operating under the terms of reference of the India-US Drug Policy Framework, the two delegations reviewed bilateral cooperation in combatting illicit drug trafficking. The discussions identified several priority areas for strengthening collaboration, including intelligence sharing, coordinated law enforcement action, precursor control, pharmaceutical supply chain integrity, and drug demand reduction.

The official statement noted that the meeting underscored the importance of sustained institutional engagement, timely intelligence exchange, and coordinated action to address emerging narcotics threats and promote demand reduction. Both sides agreed to further the sharing of best practices in targeted law enforcement topics.

During the sessions, NCB Director General Anurag highlighted India's Vision Roadmap 2026-2029, which was formulated under the guidance of Prime Minister Narendra Modi and the leadership of Union Home Minister Amit Shah.

Commenting on the partnership, ONDCP Director Sara Carter stated that the Executive Working Group and bilateral cooperation between the United States and India are vital to disrupting transnational drug trafficking networks and preventing the diversion of synthetic drugs and chemical precursors into global markets.

US Ambassador to India Sergio Gor also emphasized the operational focus of the agreement. Gor stated that protecting populations requires securing borders and cutting off illicit drug networks at the source, adding that the two countries are delivering operational results by choking off illicit precursor chemicals, securing commercial supply chains, and dismantling cartels.

"International regulatory alignment and supply chain security are critical components for global trade and public safety. Bilateral frameworks like the India-US Drug Policy Executive Working Group demonstrate how cross-border cooperation can protect pharmaceutical supply chain integrity and disrupt illicit networks. For businesses operating in regulated sectors, such governmental coordination reinforces the necessity for strict compliance, robust traceability, and secure supply chain logistics." — Dr. Shishir Gupta, Founder & CEO, StartupLanes